P53 apoptosis mediator PERP:  localization, function and caspase activation in uveal melanoma.
p53 apoptosis effector related to PMP-22 (PERP) is a transcriptional target gene of p53 tumour suppressor that is specifically induced during apoptosis and not during cell cycle arrest. In primary uveal melanoma (UM), the most common intraocular malignancy in adults that has a reportedly unaffected signalling pathway upstream of and including p53, PERP expression is down-regulated in the metastatic monosomy 3-type tumours, compared with the less aggressive disomy 3-type tumours. Here, we demonstrate experimentally, by the use of full-length PERP-green fluorescent protein (GFP) fusions and real-time confocal microscopy, the intracellular targeting and plasma membrane localization of PERP in living UM cells and show that expression of PERP induces caspase-mediated apoptosis in UM cells. Induction of PERP expression in GFP-PERP-transfected UM cells leads to increased levels of cleaved caspase-8 forms, as well as to reduction of its full-length substrate Bid, but not to detectable processing of caspase-9. The levels of mature caspase-8, -9 and -3 proteins significantly correlate with PERP expression levels in primary UMs. Transcriptional profiling of PERP and caspase-8 in tumour specimens indicates that the positive association of PERP and caspase-8 proteins is a consequence of post-translational processing, most likely at the level of caspase-8 cleavage, and not of increased transcription of pro-caspase-8. We conclude that PERP expression leads to activation of an extrinsic receptor-mediated apoptotic pathway, with a possible subsequent engagement of the intrinsic apoptotic pathway. The findings underline the apoptotic pathway mediated by PERP as a critical mechanism employed by UM tumours to modulate susceptibility to apoptosis.
Davies
Lyndsay
L
Unit of Ophthalmology, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom.
Gray
Donna
D
Unit of Ophthalmology, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom.
Spiller
Dave
D
Centre for Cell Imaging, School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom.
White
Mike R H
MRH
Centre for Cell Imaging, School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom.
Damato
Bertil
B
St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom.
Grierson
Ian
I
Unit of Ophthalmology, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom.
Paraoan
Luminita
L
Unit of Ophthalmology, School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom.
D017209:Apoptosis / Q000502:physiology*; D001483:Base Sequence; D015153:Blotting, Western; D020169:Caspases / Q000378:metabolism*; D017931:DNA Primers; D004789:Enzyme Activation; D016147:Genes, Tumor Suppressor / Q000502:physiology*; D006801:Humans; D008545:Melanoma / Q000201:enzymology / Q000378:metabolism*; D008565:Membrane Proteins / Q000502:physiology*; D016133:Polymerase Chain Reaction; D014604:Uveal Neoplasms / Q000201:enzymology / Q000378:metabolism*
D017931:DNA Primers; D008565:Membrane Proteins; C416404:PERP protein, human; D020169:Caspases